AnPac Bio-Medical Science Co., Ltd.
AnPac Bio-Medical Science Co., Ltd. (ANPC) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
anpc · pe ratio · data through Dec 31, 2022
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for AnPac Bio-Medical Science Co., Ltd. (ANPC) measures how much investors pay for each dollar of the company's trailing earnings. ANPC's current PE ratio of N/A is calculated by dividing its stock price of $4.30 by its TTM earnings per share of -$54.18.
Source: FMP · /ratios-ttm · /analyst-estimates · 2022-12-31
PE Ratio History
2017 – 2022 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
PE Ratio vs Peers
Biotechnology · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
AnPac Bio-Medical Science Co., Ltd.You ANPC | $27M | N/A | — | -$54.18 |
 Allakos Inc. ALLK | $30M | N/A | — | -$1.30 |
 Angion Biomedica Corp. ANGN | $30M | N/A | — | -$2.58 |
 Elevation Oncology, Inc. ELEV | $22M | N/A | — | -$0.78 |
 Freeline Therapeutics Holdings plc FRLN | $28M | N/A | — | -$22.52 |
 Gemini Therapeutics, Inc. GMTX | $25M | N/A | — | — |
 Liminal BioSciences Inc. LMNL | $28M | N/A | — | -$341.80 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2022-12-31Latest FY2022 | — | $-54.18 | — | |
2021-12-31 FY2021 | — | $-176.53 | — | |
2020-12-31 FY2020 | — | $-143.99 | — | |
2019-12-31 FY2019 | — | $-205.96 | — | |
2018-12-31 FY2018 | — | $-3.76 | — | |
2017-12-31 FY2017 | — | $-3.49 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for AnPac Bio-Medical Science Co., Ltd. (ANPC) measures how much investors pay for each dollar of the company's trailing earnings. ANPC's current PE ratio of N/A is calculated by dividing its stock price of $4.30 by its TTM earnings per share of -$54.18.
Frequently asked questions
ANPC pe ratio · 6 questionsANPC's current PE ratio is N/A as of 2026-06-09, based on a stock price of $4.30 and TTM EPS of -$54.18. Data sourced from Financial Modeling Prep via ANPC's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · AnPac Bio-Medical Science Co., Ltd. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09